UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 32

Sortiert nach

Menstrual migraine: what it is and does it matter?

Journal of neurology, 2021-07, Vol.268 (7), p.2355-2363

2021

Volltextzugriff (PDF)

Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Philosophical transactions of the Royal Society of London. Series B. Biological sciences, 2015-07, Vol.370 (1672)

2015

Volltextzugriff (PDF)

Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms

Journal of neuroinflammation, 2021-11, Vol.18 (1), p.259-259, Article 259

2021

Volltextzugriff (PDF)

Dural arteriovenous fistulas and headache features: an observational study

Journal of headache and pain, 2020-01, Vol.21 (1), p.6-6, Article 6

2020

Volltextzugriff (PDF)

Pathophysiological basis of migraine prophylaxis

Progress in neurobiology, 2009-10, Vol.89 (2), p.176-192

2009

Volltextzugriff (PDF)

Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks

Journal of headache and pain, 2022-07, Vol.23 (1), p.80-80, Article 80

2022

Volltextzugriff (PDF)

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine

Frontiers in neurology, 2017-12, Vol.8, p.655-655

2017

Volltextzugriff (PDF)

Effect of anti‐CGRP‐targeted therapy on migraine aura: Results of an observational case series study

CNS neuroscience & therapeutics, 2024-02, Vol.30 (2), p.e14595-n/a

2024

Volltextzugriff (PDF)

Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study

Neurology, 2018-07, Vol.91 (4), p.e364

2018

Volltextzugriff (PDF)

Immunological findings in patients with migraine and other primary headaches: a narrative review

Clinical and experimental immunology, 2022-01, Vol.207 (1), p.11-26

2022

Volltextzugriff (PDF)

Refractory focal non-convulsive status epilepticus in anti-glur2 encephalitis: Neuro-inflammation and AMPA receptors modulation as target treatment

Journal of the neurological sciences, 2021-10, Vol.429, p.119118, Article 119118

2021

Volltextzugriff (PDF)

Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?

Cephalalgia, 2018-02, Vol.38 (2), p.274-282

2018

Volltextzugriff (PDF)

Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery

The Annals of thoracic surgery, 2019-04, Vol.107 (4), p.1040-1045

2019

Volltextzugriff (PDF)

Drug-dependence behaviour and outcome of medication-overuse headache after treatment

Journal of headache and pain, 2012-11, Vol.13 (8), p.653-660

2012

Volltextzugriff (PDF)

Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial

European neuropsychopharmacology, 2014-08, Vol.24 (8), p.1289-1297

2014

Volltextzugriff (PDF)

Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

Journal of headache and pain, 2018-11, Vol.19 (1), p.101-8, Article 101

2018

Volltextzugriff (PDF)

P066. Migraine with aura in the locker room: 4 case reports

Journal of headache and pain, 2015-12, Vol.16 (Suppl 1), p.A169-1, Article A169

2015

Volltextzugriff (PDF)

Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: The results of a pilot study

Cephalalgia, 2011-04, Vol.31 (5), p.543-549

2011

Volltextzugriff (PDF)

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

Journal of headache and pain, 2018-10, Vol.19 (1), p.98-98, Article 98

2018

Volltextzugriff (PDF)

Palinopsia in patients with migraine: A case-control study

Cephalalgia, 2011-07, Vol.31 (9), p.999-1004

2011

Volltextzugriff (PDF)

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?

Journal of headache and pain, 2015-12, Vol.16 (Suppl 1), p.A69-2, Article A69

2015

Volltextzugriff (PDF)

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache

Journal of headache and pain, 2014-12, Vol.15 (1), p.88-88, Article 88

2014

Volltextzugriff (PDF)

HDAC3 role in medication consumption in medication overuse headache patients: a pilot study

Human genomics, 2015-11, Vol.9 (1), p.30-30, Article 30

2015

Volltextzugriff (PDF)

1 – 25 von 32

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(32)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(32)

Sprache

Englisch
(32)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Menstrual migraine: what it is and does it matter?

Levodopa-induced plasticity: a double-edged sword in Parkinson's disease?

Headache and immunological/autoimmune disorders: a comprehensive review of available epidemiological evidence with insights on potential underlying mechanisms

Dural arteriovenous fistulas and headache features: an observational study

Pathophysiological basis of migraine prophylaxis

Visual stimulation and frequency of focal neurological symptoms engage distinctive neurocognitive resources in migraine with aura patients: a study of resting-state functional networks

Sustained Efficacy, Safety and High Adherence Rate of Onabotulinum Toxin Type A in Chronic Migraine Patients: A Multicentric Prospective Real-Life Study

Stopping Onabotulinum Treatment after the First Two Cycles Might Not Be Justified: Results of a Real-life Monocentric Prospective Study in Chronic Migraine

Effect of anti‐CGRP‐targeted therapy on migraine aura: Results of an observational case series study

Noninvasive vagus nerve stimulation as acute therapy for migraine: The randomized PRESTO study

Immunological findings in patients with migraine and other primary headaches: a narrative review

Refractory focal non-convulsive status epilepticus in anti-glur2 encephalitis: Neuro-inflammation and AMPA receptors modulation as target treatment

Antiepileptic drugs in migraine and epilepsy: Who is at increased risk of adverse events?

Self-administered subcutaneous diclofenac sodium in acute migraine attack: A randomized, double-blind, placebo-controlled dose-finding pilot study

Interatrial Shunting Through an Asymptomatic Patent Foramen Ovale in Thoracic Surgery

Drug-dependence behaviour and outcome of medication-overuse headache after treatment

Sodium valproate in migraine without aura and medication overuse headache: A randomized controlled trial

Consistent effects of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: additional findings from the randomized, sham-controlled, double-blind PRESTO trial

P066. Migraine with aura in the locker room: 4 case reports

Migraine preventive drug-induced weight gain may be mediated by effects on hypothalamic peptides: The results of a pilot study

Practical and clinical utility of non-invasive vagus nerve stimulation (nVNS) for the acute treatment of migraine: a post hoc analysis of the randomized, sham-controlled, double-blind PRESTO trial

Palinopsia in patients with migraine: A case-control study

O064. Antiepileptic drugs in migraine and epilepsy disorders: who is at increased risk of adverse events?

Long term headache duration is a factor predicting nonresponse to detoxification and advice in medication overuse headache

HDAC3 role in medication consumption in medication overuse headache patients: a pilot study

Suchergebnisse filtern